193 related articles for article (PubMed ID: 36239935)
1. Incidence and Survival in Synchronous and Metachronous Liver Metastases From Colorectal Cancer.
Reboux N; Jooste V; Goungounga J; Robaszkiewicz M; Nousbaum JB; Bouvier AM
JAMA Netw Open; 2022 Oct; 5(10):e2236666. PubMed ID: 36239935
[TBL] [Abstract][Full Text] [Related]
2. Impact of absence of consensual cutoff time distinguishing between synchronous and metachronous metastases: illustration with colorectal cancer.
Willem H; Jooste V; Boussari O; Romain G; Bouvier AM
Eur J Cancer Prev; 2019 May; 28(3):167-172. PubMed ID: 29738323
[TBL] [Abstract][Full Text] [Related]
3. [Impact of time of occurrence of liver metastases (synchronous vs. metachronous) on early postoperative outcome and long-term survival of colorectal cancer patients].
Bova R; Kamphues C; Neuhaus P; Puhl G
Zentralbl Chir; 2014 Apr; 139(2):220-5. PubMed ID: 23846535
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study.
Mitry E; Guiu B; Cosconea S; Jooste V; Faivre J; Bouvier AM
Gut; 2010 Oct; 59(10):1383-8. PubMed ID: 20732912
[TBL] [Abstract][Full Text] [Related]
5. Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: A nationwide study.
Lurvink RJ; Bakkers C; Rijken A; van Erning FN; Nienhuijs SW; Burger JW; Creemers GJ; Verhoef C; Lemmens VE; De Hingh IH
Eur J Surg Oncol; 2021 May; 47(5):1026-1033. PubMed ID: 33272737
[TBL] [Abstract][Full Text] [Related]
6. Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population-based study.
Väyrynen V; Wirta EV; Seppälä T; Sihvo E; Mecklin JP; Vasala K; Kellokumpu I
BJS Open; 2020 Aug; 4(4):685-692. PubMed ID: 32543788
[TBL] [Abstract][Full Text] [Related]
7. METACHRONOUS COLORECTAL LIVER METASTASES HAS BETTER PROGNOSIS - IS IT TRUE?
Quireze Junior C; Brasil AMS; Morais LK; Campion ERL; Taveira EJF; Rassi MC
Arq Gastroenterol; 2018; 55(3):258-263. PubMed ID: 30540088
[TBL] [Abstract][Full Text] [Related]
8. Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
Hentzen JEKR; Rovers KP; Kuipers H; van der Plas WY; Been LB; Hoogwater FJH; van Ginkel RJ; Hemmer PHJ; van Dam GM; de Hingh IHJT; Kruijff S
Ann Surg Oncol; 2019 Jul; 26(7):2210-2221. PubMed ID: 30877495
[TBL] [Abstract][Full Text] [Related]
9. Synchronous and metachronous liver metastases in patients with colorectal cancer-towards a clinically relevant definition.
Engstrand J; Strömberg C; Nilsson H; Freedman J; Jonas E
World J Surg Oncol; 2019 Dec; 17(1):228. PubMed ID: 31878952
[TBL] [Abstract][Full Text] [Related]
10. Synchronous and metachronous liver metastases in patients with colorectal cancer.
Okholm C; Mollerup TK; Schultz NA; Strandby RB; Achiam MP
Dan Med J; 2018 Dec; 65(12):. PubMed ID: 30511638
[TBL] [Abstract][Full Text] [Related]
11. The tumour biology of synchronous and metachronous colorectal liver metastases: a systematic review.
Slesser AA; Georgiou P; Brown G; Mudan S; Goldin R; Tekkis P
Clin Exp Metastasis; 2013 Apr; 30(4):457-70. PubMed ID: 23180209
[TBL] [Abstract][Full Text] [Related]
12. The incidence and risk factors of metachronous colorectal cancer: an indication for follow-up.
Mulder SA; Kranse R; Damhuis RA; Ouwendijk RJ; Kuipers EJ; van Leerdam ME
Dis Colon Rectum; 2012 May; 55(5):522-31. PubMed ID: 22513430
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and prognosis of synchronous and metachronous colon cancer metastases: a French population-based study.
Ghiringhelli F; Hennequin A; Drouillard A; Lepage C; Faivre J; Bouvier AM
Dig Liver Dis; 2014 Sep; 46(9):854-8. PubMed ID: 24908575
[TBL] [Abstract][Full Text] [Related]
14. Survival of patients with synchronous and metachronous colorectal liver metastases--is there a difference?
Bockhorn M; Frilling A; Frühauf NR; Neuhaus J; Molmenti E; Trarbach T; Malagó M; Lang H; Broelsch CE
J Gastrointest Surg; 2008 Aug; 12(8):1399-405. PubMed ID: 18521698
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis.
Tsai MS; Su YH; Ho MC; Liang JT; Chen TP; Lai HS; Lee PH
Ann Surg Oncol; 2007 Feb; 14(2):786-94. PubMed ID: 17103254
[TBL] [Abstract][Full Text] [Related]
16. [Epidemiology of colorectal cancer liver metastases].
Faivre J; Manfredi S; Bouvier AM
Bull Acad Natl Med; 2003; 187(5):815-22; discussion 822-3. PubMed ID: 14979048
[TBL] [Abstract][Full Text] [Related]
17. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.
van Gestel YR; Thomassen I; Lemmens VE; Pruijt JF; van Herk-Sukel MP; Rutten HJ; Creemers GJ; de Hingh IH
Eur J Surg Oncol; 2014 Aug; 40(8):963-9. PubMed ID: 24183168
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features and prognosis of synchronous and metachronous colorectal cancer: a retrospective cohort study.
Fan H; Wen R; Zhou L; Gao X; Lou Z; Hao L; Meng R; Gong H; Yu G; Zhang W
Int J Surg; 2023 Dec; 109(12):4073-4090. PubMed ID: 37737848
[TBL] [Abstract][Full Text] [Related]
19. Higher incidence of metachronous advanced neoplasia in patients with synchronous advanced neoplasia and left-sided colorectal resection for colorectal cancer.
Yabuuchi Y; Imai K; Hotta K; Ito S; Kishida Y; Yamaguchi T; Shiomi A; Kinugasa Y; Yoshida M; Tanaka M; Kawata N; Kakushima N; Takizawa K; Ishiwatari H; Matsubayashi H; Ono H
Gastrointest Endosc; 2018 Aug; 88(2):348-359.e1. PubMed ID: 29574125
[TBL] [Abstract][Full Text] [Related]
20. Significant increase of synchronous disease in first-line metastatic colorectal cancer trials: Results of a systematic review.
Goey KK; 't Lam-Boer J; de Wilt JH; Punt CJ; van Oijen MG; Koopman M
Eur J Cancer; 2016 Dec; 69():166-177. PubMed ID: 27821320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
